BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29130625)

  • 1. Comparative evaluation of
    Satpati D; Sharma R; Sarma HD; Dash A
    Chem Biol Drug Des; 2018 Mar; 91(3):781-788. PubMed ID: 29130625
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Vats K; Sharma R; Sarma HD; Satpati D; Dash A
    Anticancer Agents Med Chem; 2018; 18(9):1289-1294. PubMed ID: 29546835
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
    Medchemcomm; 2017 Mar; 8(3):673-679. PubMed ID: 30108785
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G
    Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative preclinical evaluation of
    Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
    J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Satpati D; Vats K; Sharma R; Sarma HD; Dash A
    J Pept Sci; 2020 Mar; 26(3):e3241. PubMed ID: 31984553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in negative charge of
    Rinne SS; Dahlsson Leitao C; Gentry J; Mitran B; Abouzayed A; Tolmachev V; Ståhl S; Löfblom J; Orlova A
    Sci Rep; 2019 Nov; 9(1):17710. PubMed ID: 31776413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the monomeric [
    Israel I; Elflein K; Schirbel A; Chen K; Samnick S
    Eur J Pharm Sci; 2021 Nov; 166():105964. PubMed ID: 34375678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and comparative evaluation of
    Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Banerjee S
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):68-76. PubMed ID: 29139598
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mittal S; Sharma R; Mallia MB; Sarma HD
    Nucl Med Biol; 2021; 96-97():61-67. PubMed ID: 33838524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
    Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
    Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemical synthesis and preclinical evaluation of
    Hajdu I; Angyal J; Szikra D; Kertész I; Malanga M; Fenyvesi É; Szente L; Vecsernyés M; Bácskay I; Váradi J; Fehér P; Ujhelyi Z; Vasvári G; Rusznyák Á; Trencsényi G; Fenyvesi F
    Eur J Pharm Sci; 2019 Feb; 128():202-208. PubMed ID: 30521943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of
    Zhao R; Ploessl K; Zha Z; Choi S; Alexoff D; Zhu L; Kung HF
    Mol Pharm; 2020 Dec; 17(12):4589-4602. PubMed ID: 33108189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
    Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.
    Altai M; Strand J; Rosik D; Selvaraju RK; Eriksson Karlström A; Orlova A; Tolmachev V
    Bioconjug Chem; 2013 Jun; 24(6):1102-9. PubMed ID: 23705574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of
    Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J
    Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.